AKT1 and cancer: Our study firstly confirmed that the A–S drug pair and their extracts (Astragaloside IV and PESV) promoted the expression of LC3 protein in cancer tissues and inhibited the expression of P62 and PI3K–AKT pathway proteins, and then inhibited the formation of PCa in mice.